E. Aslanger Et Al. , "Intrarenal application of N-acetylcysteine for the prevention of contrast medium-induced nephropathy in primary angioplasty," CORONARY ARTERY DISEASE , vol.23, no.4, pp.265-270, 2012
Aslanger, E. Et Al. 2012. Intrarenal application of N-acetylcysteine for the prevention of contrast medium-induced nephropathy in primary angioplasty. CORONARY ARTERY DISEASE , vol.23, no.4 , 265-270.
Aslanger, E., Uslu, B., Akdeniz, C., Polat, N., Cizgici, Y., & Oflaz, H., (2012). Intrarenal application of N-acetylcysteine for the prevention of contrast medium-induced nephropathy in primary angioplasty. CORONARY ARTERY DISEASE , vol.23, no.4, 265-270.
Aslanger, Emre Et Al. "Intrarenal application of N-acetylcysteine for the prevention of contrast medium-induced nephropathy in primary angioplasty," CORONARY ARTERY DISEASE , vol.23, no.4, 265-270, 2012
Aslanger, Emre Et Al. "Intrarenal application of N-acetylcysteine for the prevention of contrast medium-induced nephropathy in primary angioplasty." CORONARY ARTERY DISEASE , vol.23, no.4, pp.265-270, 2012
Aslanger, E. Et Al. (2012) . "Intrarenal application of N-acetylcysteine for the prevention of contrast medium-induced nephropathy in primary angioplasty." CORONARY ARTERY DISEASE , vol.23, no.4, pp.265-270.
@article{article, author={Emre Aslanger Et Al. }, title={Intrarenal application of N-acetylcysteine for the prevention of contrast medium-induced nephropathy in primary angioplasty}, journal={CORONARY ARTERY DISEASE}, year=2012, pages={265-270} }